Quinolinic acid formation in immune-activated mice:: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl) thiazol-2yl]-benzenesulfonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase

被引:32
作者
Chiarugi, A [1 ]
Moroni, F [1 ]
机构
[1] Univ Florence, Dept Preclin & Clin Pharmacol, I-50134 Florence, Italy
关键词
quinolinic acid; immune-stimulation; kynurenine; selective kynurenine hydroxylase inhibitor; mNBA;
D O I
10.1016/S0028-3908(99)00048-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of kynurenine hydroxylase activity in the neo-formation of the excitotoxin quinolinic acid (QUIN) has been studied in mice by using (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl) thiazol-2yl]-benzenesulfonamide (Ro 61-8048), two potent and selective inhibitors of this enzyme. Immune-stimulation with pokeweed mitogen (PWM, 200 mu g i.v., 12 h) induced a robust increase in kynurenine (KYN) and its metabolites kynurenic acid (KYNA) and QUIN in blood and brain. When incubated in a medium containing KYN but not tryptophan, spleen, lung and liver (but not brain) slices accumulated a measurable amount of QUIN in the supernatant. Slices obtained from PWM treated animals had a ten-fold increase in QUIN accumulation in spleen, no changes in lung and a 40% decrease in liver, suggesting that the spleen contributes to the increased QUIN levels found in the blood and brain of immune-stimulated mice. Large doses of kynurenine hydroxylase inhibitors increased KYN and KYNA, but unexpectedly did not decrease QUIN content in control blood and brain. When tested in organ slices obtained from either controls or immune-stimulated animals, mNBA (1-1000 mu M) and Ro 61-8048 (0.1-100 mu M) strongly reduced QUIN neo-formation, suggesting that, in vitro, kynurenine hydroxylase activity is required for QUIN neosynthesis. Indeed, after repeated doses of, mNBA or Ro 61-8048, QUIN content in blood and brain of immune-stimulated animals significantly decreased. Our results suggest that, under basal conditions, sufficient QUIN synthesis may occur through kynurenine hydroxylase-independent pathways. In immune-stimulated animals, however, kynurenine hydroxylase inhibitors significantly reduce blood and brain accumulation of QUIN. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1225 / 1233
页数:9
相关论文
共 40 条
[11]   KYNURENIC ACID BLOCKS NEUROTOXICITY AND SEIZURES INDUCED IN RATS BY THE RELATED BRAIN METABOLITE QUINOLINIC ACID [J].
FOSTER, AC ;
VEZZANI, A ;
FRENCH, ED ;
SCHWARCZ, R .
NEUROSCIENCE LETTERS, 1984, 48 (03) :273-278
[12]   ON THE EXCITOTOXIC PROPERTIES OF QUINOLINIC ACID, 2,3-PIPERIDINE DICARBOXYLIC-ACIDS AND STRUCTURALLY RELATED-COMPOUNDS [J].
FOSTER, AC ;
COLLINS, JF ;
SCHWARCZ, R .
NEUROPHARMACOLOGY, 1983, 22 (12) :1331-&
[13]   QUINOLINIC ACID IN CEREBROSPINAL-FLUID AND SERUM IN HIV-1 INFECTION - RELATIONSHIP TO CLINICAL AND NEUROLOGICAL STATUS [J].
HEYES, MP ;
BREW, BJ ;
MARTIN, A ;
PRICE, RW ;
SALAZAR, AM ;
SIDTIS, JJ ;
YERGEY, JA ;
MOURADIAN, MM ;
SADLER, AE ;
KEILP, J ;
RUBINOW, D ;
MARKEY, SP .
ANNALS OF NEUROLOGY, 1991, 29 (02) :202-209
[14]   RELATIONSHIP OF NEUROLOGIC STATUS IN MACAQUES INFECTED WITH THE SIMIAN IMMUNODEFICIENCY VIRUS TO CEREBROSPINAL-FLUID QUINOLINIC ACID AND KYNURENIC ACID [J].
HEYES, MP ;
JORDAN, EK ;
LEE, K ;
SAITO, K ;
FRANK, JA ;
SNOY, PJ ;
MARKEY, SP ;
GRAVELL, M .
BRAIN RESEARCH, 1992, 570 (1-2) :237-250
[15]   QUANTIFICATION OF QUINOLINIC ACID IN RAT-BRAIN, WHOLE-BLOOD, AND PLASMA BY GAS-CHROMATOGRAPHY AND NEGATIVE CHEMICAL IONIZATION MASS-SPECTROMETRY - EFFECTS OF SYSTEMIC L-TRYPTOPHAN ADMINISTRATION ON BRAIN AND BLOOD QUINOLINIC ACID CONCENTRATIONS [J].
HEYES, MP ;
MARKEY, SP .
ANALYTICAL BIOCHEMISTRY, 1988, 174 (01) :349-359
[16]   HUMAN MACROPHAGES CONVERT L-TRYPTOPHAN INTO THE NEUROTOXIN QUINOLINIC ACID [J].
HEYES, MP ;
SAITO, K ;
MARKEY, SP .
BIOCHEMICAL JOURNAL, 1992, 283 :633-635
[17]   A MECHANISM OF QUINOLINIC ACID FORMATION BY BRAIN IN INFLAMMATORY NEUROLOGICAL DISEASE - ATTENUATION OF SYNTHESIS FROM L-TRYPTOPHAN BY 6-CHLOROTRYPTOPHAN AND 4-CHLORO-3-HYDROXYANTHRANILATE [J].
HEYES, MP ;
SAITO, K ;
MAJOR, EO ;
MILSTIEN, S ;
MARKEY, SP ;
VICKERS, JH .
BRAIN, 1993, 116 :1425-1450
[18]   DETERMINATION OF SERUM KYNURENINE AND HEPATIC TRYPTOPHAN DIOXYGENASE ACTIVITY BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
HOLMES, EW .
ANALYTICAL BIOCHEMISTRY, 1988, 172 (02) :518-525
[19]   Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages [J].
Kerr, SJ ;
Armati, PJ ;
Pemberton, LA ;
Smythe, G ;
Tattam, B ;
Brew, BJ .
NEUROLOGY, 1997, 49 (06) :1671-1681
[20]   ANTIBODIES TO QUINOLINIC ACID REVEAL LOCALIZATION IN SELECT IMMUNE CELLS RATHER THAN NEURONS OR ASTROGLIA [J].
MOFFETT, JR ;
ESPEY, MG ;
GAUDET, SJ ;
NAMBOODIRI, MAA .
BRAIN RESEARCH, 1993, 623 (02) :337-340